According to a report by Malaya on June 4, Philippine Senator Joel Villanueva called for a review of Senate Bill 11990, also known as the "Vaporized Nicotine and Non-Nicotine Products Regulation Act," in order to transfer regulatory authority over e-cigarette products to the Food and Drug Administration (FDA) instead of the Department of Trade and Industry (DTI).
The legislator stated that despite the official implementation of Bill 11990 in 2022, amendments are urgently needed due to the increasing health issues related to e-cigarettes. Additionally, the Ministry of Trade and Industry's efficiency in banning illegal e-cigarette shops is low and needs to be addressed immediately.
I support the FDA's investigation into this matter and its regulation. There are issues with the enforcement or implementation of this law. The issue should be resolved by the FDA instead of the DTI.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
